Regulacje i polityka gospodarcza · 21/11/2014

FDA Proposes New Clinical Trial Registration and Results Submission Requirements

The FDA proposes new rules requiring the registration and submission of clinical trial results, including adverse event information, to ClinicalTrials.gov, a database that tracks clinical trials and their outcomes. The proposed rule aims to enhance patient enrollment, track trial progress, and improve access to trial results.